Product Information
CYCLOPHOSPHAMIDE 25 MG CAPSULE is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $1.1212 per EA under NDC 00054038225. Its NADAC has been published 106 times since Jun 19, 2024.
Strength
25 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054038225
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
2/18/2026
Active Ingredients
CYCLOPHOSPHAMIDEApproval Type
New Drug (NDA)
FDA Application
NDA203856On Market Since
9/16/2013
Price Statistics
The NADAC for CYCLOPHOSPHAMIDE 25 MG CAPSULE has been published 106 times since Jun 19, 2024, and over the history we have for it it has declined 56.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1212 per EA |
|---|---|
| All-time high | $2.5986 (Jul 10, 2024) |
| All-time low | $0.9952 (Sep 17, 2025) |
| 52-week high | $2.4065 |
| 52-week low | $0.9952 |
| Median price | $2.0975 |
| Average price | $1.7999 |
| Largest weekly change | -56.0% (Aug 20, 2025) |
| Weeks tracked | 106 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CYCLOPHOSPHAMIDE 25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOPHOSPHAMIDE 25 MG CAPSULE, manufactured by Hikma Pharmaceuticals USA Inc., is $1.1212 per EA (NDC 00054038225), effective Jun 24, 2026.
How has the price of CYCLOPHOSPHAMIDE 25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CYCLOPHOSPHAMIDE 25 MG CAPSULE has declined 56.9%. It has been tracked across 106 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for CYCLOPHOSPHAMIDE 25 MG CAPSULE?
Since Jun 19, 2024, the NADAC for CYCLOPHOSPHAMIDE 25 MG CAPSULE has ranged from a low of $0.9952 (Sep 17, 2025) to a high of $2.5986 (Jul 10, 2024), with a median of $2.0975 per EA.
Are there cheaper alternatives to CYCLOPHOSPHAMIDE 25 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as CYCLOPHOSPHAMIDE 25 MG CAPSULE, but none are currently priced below it.
Who manufactures CYCLOPHOSPHAMIDE 25 MG CAPSULE?
CYCLOPHOSPHAMIDE 25 MG CAPSULE (NDC 00054038225) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification